Cargando…
The Role of Aggregates of Therapeutic Protein Products in Immunogenicity: An Evaluation by Mathematical Modeling
Therapeutic protein products (TPP) have been widely used to treat a variety of human diseases, including cancer, hemophilia, and autoimmune diseases. However, TPP can induce unwanted immune responses that can impact both drug efficacy and patient safety. The presence of aggregates is of particular c...
Autores principales: | Yin, Liusong, Chen, Xiaoying, Tiwari, Abhinav, Vicini, Paolo, Hickling, Timothy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670651/ https://www.ncbi.nlm.nih.gov/pubmed/26682236 http://dx.doi.org/10.1155/2015/401956 |
Ejemplares similares
-
A Mechanistic, Multiscale Mathematical Model of Immunogenicity for Therapeutic Proteins: Part 2—Model Applications
por: Chen, X, et al.
Publicado: (2014) -
A Mechanistic, Multiscale Mathematical Model of Immunogenicity for Therapeutic Proteins: Part 1—Theoretical Model
por: Chen, X, et al.
Publicado: (2014) -
Immunogenicity of therapeutic proteins: Influence of aggregation
por: Ratanji, Kirsty D., et al.
Publicado: (2014) -
Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies
por: Lundahl, Mimmi L. E., et al.
Publicado: (2021) -
Immunogenicity of Bioproducts: Cellular Models to Evaluate the Impact of Therapeutic Antibody Aggregates
por: Nabhan, Myriam, et al.
Publicado: (2020)